Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123038) titled 'A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic' on Aug. 7.

Study Type: Observational

Primary Sponsor: Sonoma Biotherapeutics, Inc.

Condition: Rheumatoid Arthritis (RA) Hidradenitis Suppurativa (HS)

Intervention: Other: Long Term Safety Monitoring Procedures

Recruitment Status: Recruiting

Date of First Enrollment: July 22, 2025

Target Sample Size: 36

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07123038

Published by HT Digital Content Services with permissi...